High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study).

Jae-Hoon Song, Sook-In Jung, Kwan Soo Ko, Na Young Kim, Jun Seong Son, Hyun-Ha Chang, Hyun Kyun Ki, Won Sup Oh, Ji Yoeun Suh, Kyong Ran Peck, Nam Yong Lee, Yonghong Yang, Quan Lu, Anan Chongthaleong, Cheng-Hsun Chiu, M K Lalitha, Jennifer Perera, Ti Teow Yee, Gamini Kumarasinghe, Farida Jamal, Adeeba Kamarulzaman, Navaratnam Parasakthi, Pham Hung Van, Celia Carlos, Thomas So, Tak Keung Ng, Atef Shibl
Author Information
  1. Jae-Hoon Song: Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Asian-Pacific Research Foundation for Infectious Diseases, 50 Il-won dong, Kangnam-ku, Seoul 135-710, Korea. jhsong@smc.samsung.co.kr

Abstract

A total of 685 clinical Streptococcus pneumoniae isolates from patients with pneumococcal diseases were collected from 14 centers in 11 Asian countries from January 2000 to June 2001. The in vitro susceptibilities of the isolates to 14 antimicrobial agents were determined by the broth microdilution test. Among the isolates tested, 483 (52.4%) were not susceptible to penicillin, 23% were intermediate, and 29.4% were penicillin resistant (MICs >/= 2 mg/liter). Isolates from Vietnam showed the highest prevalence of penicillin resistance (71.4%), followed by those from Korea (54.8%), Hong Kong (43.2%), and Taiwan (38.6%). The penicillin MICs at which 90% of isolates are inhibited (MIC(90)s) were 4 mg/liter among isolates from Vietnam, Hong Kong, Korea, and Taiwan. The prevalence of erythromycin resistance was also very high in Vietnam (92.1%), Taiwan (86%), Korea (80.6%), Hong Kong (76.8%), and China (73.9%). The MIC(90)s of erythromycin were >32 mg/liter among isolates from Korea, Vietnam, China, Taiwan, Singapore, Malaysia, and Hong Kong. Isolates from Hong Kong showed the highest rate of ciprofloxacin resistance (11.8%), followed by isolates from Sri Lanka (9.5%), the Philippines (9.1%), and Korea (6.5%). Multilocus sequence typing showed that the spread of the Taiwan(19F) clone and the Spain(23F) clone could be one of the major reasons for the rapid increases in antimicrobial resistance among S. pneumoniae isolates in Asia. Data from the multinational surveillance study clearly documented distinctive increases in the prevalence rates and the levels of antimicrobial resistance among S. pneumoniae isolates in many Asian countries, which are among the highest in the world published to date.

References

  1. Antimicrob Agents Chemother. 1999 Jun;43(6):1480-3 [PMID: 10348775]
  2. J Clin Microbiol. 1999 Apr;37(4):897-901 [PMID: 10074498]
  3. Clin Infect Dis. 1999 Nov;29(5):1186-8 [PMID: 10524961]
  4. Antimicrob Agents Chemother. 1999 Nov;43(11):2612-23 [PMID: 10543737]
  5. Am J Public Health. 2000 Feb;90(2):223-9 [PMID: 10667183]
  6. Antimicrob Agents Chemother. 2000 Mar;44(3):484-8 [PMID: 10681307]
  7. Antimicrob Agents Chemother. 2001 Feb;45(2):636-8 [PMID: 11158772]
  8. Antimicrob Agents Chemother. 2001 May;45(5):1578-80 [PMID: 11302833]
  9. Clin Infect Dis. 2001 May 15;32(10):1463-9 [PMID: 11317248]
  10. J Clin Microbiol. 2001 Jul;39(7):2565-71 [PMID: 11427569]
  11. J Antimicrob Chemother. 2001 Nov;48(5):659-65 [PMID: 11679555]
  12. Emerg Infect Dis. 2001 Sep-Oct;7(5):906-8 [PMID: 11747711]
  13. N Engl J Med. 2002 Feb 21;346(8):630-1 [PMID: 11856810]
  14. N Engl J Med. 2002 Mar 7;346(10):747-50 [PMID: 11882730]
  15. J Clin Microbiol. 2002 Apr;40(4):1522-5 [PMID: 11923387]
  16. Antimicrob Agents Chemother. 2002 May;46(5):1295-301 [PMID: 11959559]
  17. Microb Drug Resist. 2002 Spring;8(1):27-33 [PMID: 12002646]
  18. J Antimicrob Chemother. 2002 Jul;50 Suppl:1-5 [PMID: 12077153]
  19. Diagn Microbiol Infect Dis. 2002 Jun;43(2):163-5 [PMID: 12088625]
  20. Clin Infect Dis. 2002 Aug 15;35(4):420-7 [PMID: 12145726]
  21. J Antimicrob Chemother. 2002 Sep;50 Suppl S1:39-47 [PMID: 12239227]
  22. J Antimicrob Chemother. 2002 Dec;50 Suppl S2:87-92 [PMID: 12556438]
  23. J Bacteriol. 2003 Jun;185(11):3307-16 [PMID: 12754228]
  24. J Antimicrob Chemother. 2004 Mar;53(3):457-63 [PMID: 14963068]
  25. Rev Infect Dis. 1991 Jan-Feb;13(1):56-60 [PMID: 2017632]
  26. Pediatrics. 1998 Sep;102(3 Pt 1):538-45 [PMID: 9738174]
  27. Microbiology. 1998 Nov;144 ( Pt 11):3049-60 [PMID: 9846740]
  28. Eur J Clin Microbiol Infect Dis. 1998 Dec;17(12):834-8 [PMID: 10052545]
  29. Clin Infect Dis. 1999 Jun;28(6):1206-11 [PMID: 10451154]

MeSH Term

Anti-Infective Agents
Asia
Drug Resistance, Bacterial
Erythromycin
Fluoroquinolones
Humans
Microbial Sensitivity Tests
Middle East
Penicillin Resistance
Pneumococcal Infections
Population Surveillance
Risk Factors
Streptococcus pneumoniae

Chemicals

Anti-Infective Agents
Fluoroquinolones
Erythromycin

Word Cloud

Created with Highcharts 10.0.0isolatesresistanceamongKoreaHongKongTaiwanpneumoniaeantimicrobialpenicillinVietnamprevalence4%mg/litershowedhighest8%clinicalStreptococcus1411AsiancountriesMICsIsolatesfollowed6%MIC90serythromycin1%China95%cloneincreasesSAsiastudytotal685patientspneumococcaldiseasescollectedcentersJanuary2000June2001vitrosusceptibilitiesagentsdeterminedbrothmicrodilutiontestAmongtested48352susceptible23%intermediate29resistant>/=27154432%3890%inhibited4alsohigh9286%8076739%>32SingaporeMalaysiarateciprofloxacinSriLankaPhilippines6Multilocussequencetypingspread19FSpain23FonemajorreasonsrapidDatamultinationalsurveillanceclearlydocumenteddistinctiverateslevelsmanyworldpublisheddateHighANSORP

Similar Articles

Cited By